Serum exosomes accelerate diabetic wound healing by promoting angiogenesis and ECM formation
- PMID: 33991016
- DOI: 10.1002/cbin.11627
Serum exosomes accelerate diabetic wound healing by promoting angiogenesis and ECM formation
Abstract
Nonhealing wounds in diabetes remain a global clinical and research challenge. Exosomes are primary mediators of cell paracrine action, which are shown to promote tissue repair and regeneration. In this study, we investigated the effects of serum derived exosomes (Serum-Exos) on diabetic wound healing and its possible mechanisms. Serum-Exos were isolated from blood serum of normal healthy mice and identified by transmission electron microscopy and western blot. The effects of Serum-Exos on diabetic wound healing, fibroblast growth and migration, angiogenesis and extracellular matrix (ECM) formation were investigated. Our results showed that the isolated Serum-Exos exhibited a sphere-shaped morphology with a mean diameter at 150 nm, and expressed classical markers of exosomes including HSP70, TSG101, and CD63. Treatment with Serum-Exos elevated the percentage of wound closure and shortened the time of healing in diabetic mice. Mechanistically, Serum-Exos promoted granulation tissue formation and increased the expression of CD31, fibronectin and collagen-ɑ in diabetic mice. Serum-Exos also promoted the migration of NIH/3T3 cells, which was associated with increased expression levels of PCNA, Ki67, collagen-α and fibronectin. In addition, Serum-Exos enhanced tube formation in human umbilical vein endothelial cells and induced the expression of CD31 at both protein and messenger RNA levels. Collectively, our results suggest that Serum-Exos may facilitate the wound healing in diabetic mice by promoting angiogenesis and ECM formation, and show the potential application in treating diabetic wounds.
Keywords: angiogenesis; diabetic healing; extracellular matrix; migration; serum exosomes.
© 2021 International Federation for Cell Biology.
Similar articles
-
Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis.J Nanobiotechnology. 2021 May 21;19(1):150. doi: 10.1186/s12951-021-00894-5. J Nanobiotechnology. 2021. PMID: 34020670 Free PMC article.
-
Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis.Theranostics. 2018 Feb 7;8(6):1607-1623. doi: 10.7150/thno.22958. eCollection 2018. Theranostics. 2018. PMID: 29556344 Free PMC article.
-
Empagliflozin-Pretreated MSC-Derived Exosomes Enhance Angiogenesis and Wound Healing via PTEN/AKT/VEGF Pathway.Int J Nanomedicine. 2025 Apr 22;20:5119-5136. doi: 10.2147/IJN.S512074. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40297404 Free PMC article.
-
Exosomes from mesenchymal stem cells: Potential applications in wound healing.Life Sci. 2024 Nov 15;357:123066. doi: 10.1016/j.lfs.2024.123066. Epub 2024 Sep 19. Life Sci. 2024. PMID: 39306326 Review.
-
Exosomes from adipose-derived stem cells and application to skin wound healing.Cell Prolif. 2021 Mar;54(3):e12993. doi: 10.1111/cpr.12993. Epub 2021 Jan 17. Cell Prolif. 2021. PMID: 33458899 Free PMC article. Review.
Cited by
-
Therapeutic application of mesenchymal stem cell-derived exosomes in skin wound healing.Front Bioeng Biotechnol. 2024 Aug 5;12:1428793. doi: 10.3389/fbioe.2024.1428793. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39161350 Free PMC article. Review.
-
In Vitro and In Vivo Evaluation of Epidermal Growth Factor (EGF) Loaded Alginate-Hyaluronic Acid (AlgHA) Microbeads System for Wound Healing.J Funct Biomater. 2023 Jul 28;14(8):403. doi: 10.3390/jfb14080403. J Funct Biomater. 2023. PMID: 37623648 Free PMC article.
-
Future applications of exosomes delivering resolvins and cytokines in facilitating diabetic foot ulcer healing.World J Diabetes. 2023 Jan 15;14(1):35-47. doi: 10.4239/wjd.v14.i1.35. World J Diabetes. 2023. PMID: 36684384 Free PMC article. Review.
-
microRNAs delivered by small extracellular vesicles in MSCs as an emerging tool for bone regeneration.Front Bioeng Biotechnol. 2023 Aug 31;11:1249860. doi: 10.3389/fbioe.2023.1249860. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37720323 Free PMC article. Review.
-
Exosomes Derived from Mouse Breast Carcinoma Cells Facilitate Diabetic Wound Healing.Tissue Eng Regen Med. 2024 Jun;21(4):571-586. doi: 10.1007/s13770-024-00629-1. Epub 2024 Mar 12. Tissue Eng Regen Med. 2024. PMID: 38472732 Free PMC article.
References
REFERENCES
-
- Alexiadou, K. , & Doupis, J. (2012). Management of diabetic foot ulcers. Diabetes Therapy, 3(1), 4. https://doi.org/10.1007/s13300-012-0004-9
-
- An, Y. , Liu, W. J. , Xue, P. , Ma, Y. , Zhang, L. Q. , Zhu, B. , Qi, M. , Li, L. Y. , Zhang, Y. J. , Wang, Q. T. , & Jin, Y. (2018). Autophagy promotes MSC-mediated vascularization in cutaneous wound healing via regulation of VEGF secretion. Cell Death & Disease, 9(2), 58. https://doi.org/10.1038/s41419-017-0082-8.
-
- Bagonza, J. , Rutebemberwa, E. , & Bazeyo, W. (2015). Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Services Research, 15, 168. https://doi.org/10.1186/s12913-015-0820-5
-
- Bekele, F. , & Chelkeba, L. (2020). Amputation rate of diabetic foot ulcer and associated factors in diabetes mellitus patients admitted to Nekemte referral hospital, western Ethiopia: Prospective observational study. Journal of Foot and Ankle Research, 13(1), 65. https://doi.org/10.1186/s13047-020-00433-9
-
- Chen, C. Y. , Rao, S. S. , Ren, L. , Hu, X. K. , Tan, Y. J. , Hu, Y. , Luo, J. , Liu, Y. W. , Yin, H. , Huang, J. , Cao, J. , Wang, Z. X. , Liu, Z. Z. , Liu, H. M. , Tang, S. Y. , Xu, R. , & Xie, H. (2018). Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics, 8(6), 1607-1623. https://doi.org/10.7150/thno.22958
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous